PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-34.85%
G&A reduction while CRON.TO shows 0.00% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-34.85%
Operating expenses reduction while CRON.TO shows 0.00% growth. Joel Greenblatt would examine advantage.
-34.85%
Total costs reduction while CRON.TO shows 0.00% growth. Joel Greenblatt would examine advantage.
-32.81%
Interest expense reduction while CRON.TO shows 0.00% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
34.84%
EBITDA change of 34.84% while CRON.TO is flat. Bruce Berkowitz would examine quality.
No Data
No Data available this quarter, please select a different quarter.
34.84%
Income change of 34.84% while CRON.TO is flat. Bruce Berkowitz would examine quality.
No Data
No Data available this quarter, please select a different quarter.
-32.81%
Other expenses reduction while CRON.TO shows 0.00% growth. Joel Greenblatt would examine advantage.
34.95%
Income change of 34.95% while CRON.TO is flat. Bruce Berkowitz would examine quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
34.95%
Income change of 34.95% while CRON.TO is flat. Bruce Berkowitz would examine quality.
No Data
No Data available this quarter, please select a different quarter.
34.48%
EPS change of 34.48% while CRON.TO is flat. Bruce Berkowitz would examine quality.
34.48%
Diluted EPS change of 34.48% while CRON.TO is flat. Bruce Berkowitz would examine quality.
0.38%
Share count change of 0.38% while CRON.TO is stable. Bruce Berkowitz would verify approach.
0.38%
Diluted share change of 0.38% while CRON.TO is stable. Bruce Berkowitz would verify approach.